EUVIMEDEUVIMED entdecken
Korrektur

Correction to Chemically Modified Platforms for Better RNA Therapeutics

Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li iD, Seyoung Koo, Qimanguli Saiding, Na Kong iD, Gang Liu iD, Wei Chen iD, Wei Tao iD

Chemical Reviews · 22.05.2024 · 124 (10) · 6690-6692

DOI: 10.1021/acs.chemrev.4c00191 ↗

Kurz gefasst

Korrektur in der Zeitschrift Chemical Reviews, online erschienen am 30.04.2024. Verfasst von Yesi Shi und 9 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Gefördert von: Novo Nordisk, American Heart Association, Harvard Medical School.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

ORCID-Profile: Yongjiang Li, Na Kong, Gang Liu, Wei Chen, Wei Tao

Förderung

  • Novo Nordisk
  • American Heart Association
  • Harvard Medical School
  • American Lung Association
  • Brigham Research Institute
  • Nanotechnology Foundation
  • Khoury College of Computer Sciences

Zitieren

APA

Shi, Y., Zhen, X., Zhang, Y., Li, Y., Koo, S., Saiding, Q., Kong, N., Liu, G., Chen, W., & Tao, W. (2024). Correction to Chemically Modified Platforms for Better RNA Therapeutics. Chemical Reviews, 124(10), 6690-6692. https://doi.org/10.1021/acs.chemrev.4c00191

Vancouver

Shi Y, Zhen X, Zhang Y, Li Y, Koo S, Saiding Q, et al. Correction to Chemically Modified Platforms for Better RNA Therapeutics. Chemical Reviews. 2024;124(10):6690-6692. doi:10.1021/acs.chemrev.4c00191

BibTeX
@article{Shi2024,
  author = {Shi, Yesi and Zhen, Xueyan and Zhang, Yiming and Li, Yongjiang and Koo, Seyoung and Saiding, Qimanguli and Kong, Na and Liu, Gang and Chen, Wei and Tao, Wei},
  title = {Correction to Chemically Modified Platforms for Better RNA Therapeutics},
  journal = {Chemical Reviews},
  year = {2024},
  volume = {124},
  number = {10},
  pages = {6690--6692},
  doi = {10.1021/acs.chemrev.4c00191}
}
Kostenlos starten →